{"name":"BBB-Therapeutics B.V.","slug":"bbb-therapeutics-b-v","ticker":"","exchange":"","domain":"","description":"BBB-Therapeutics B.V. is a biotechnology company focused on developing innovative treatments for serious diseases. The company has a pipeline of four drugs, with two in Phase 1 and one in Phase 2 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"2B3-101","genericName":"2B3-101","slug":"2b3-101","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"2B3-101","genericName":"2B3-101","slug":"2b3-101","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxONlFLbnNHbFZ3TkJrc2YtZ3FsRThMNW1aaHp1d1U0SVVGV09ZLWRXa1BmYVkzSks5SVVaMlAyMnROb0tFeXhLQmFoME15SFcwd1FyMzdZSHRzQXhNZGJqSGE4NDI1Q3loODl5emQzWnlMNmExcTQ1QWtYOGlzekY1d0R0VGV1THJjQTlzc2Z3V0xQMVE1d1Y3bmdrWjN2Um5OQUEzOUhZcXFGOHczVlIwVll5UkVtb2hvY2UtaFlOS3M?oc=5","date":"2025-11-17","type":"pipeline","source":"Fierce Biotech","summary":"Breaking Barriers and Crossing Borders: JCR Pharma Launches into Next 50 Years of Innovation with Global Alliances - Fierce Biotech","headline":"Breaking Barriers and Crossing Borders: JCR Pharma Launches into Next 50 Years of Innovation with Global Alliances","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOWUg4SWNXSmpoVkc4Y205YjBKTGowckRWcDFLZFVEel9CR3pxbW1YdWZHVzVjVXRBZEcwT3JZdmFNeWkya0xEMmgzZW0tNmU5aGJvRU1Oc2YtMHFkcXFodGdSWm5RZDlpVkxQWGNoSjdCdTNZMGhJdGtxcGVvUTVRWFhiZGgxT09CRHJ2N0VLMmU2dWtveWc?oc=5","date":"2024-06-24","type":"pipeline","source":"Frontiers","summary":"Receptor-mediated transcytosis for brain delivery of therapeutics: receptor classes and criteria - Frontiers","headline":"Receptor-mediated transcytosis for brain delivery of therapeutics: receptor classes and criteria","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNaGFRMHFFVlBvMWJDa2x0b1Fzb0FiVTBMVDFWem52YWRIS3V1a0RnUnQ4V0hpU2QtMTdMLTAyOC02LWV5dWd2NzZzNDlMTkhXRmxvazhVMUY4SERoV2E0YmxmNFBhR1J1N3BxNDN2anpSYXVfZlZXQXZYcW9OY2loMTVITDlZeW1GMEpibTg2TmNDaGVYX2ZLNjlqZk1leWR1ekE?oc=5","date":"2024-01-31","type":"deal","source":"Contract Pharma","summary":"Pharmaceutical Industry Mergers & Acquisitions Roundup - Contract Pharma","headline":"Pharmaceutical Industry Mergers & Acquisitions Roundup","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOaVM4UVVCVnlGMTdLRHpYSGltN2NaenJWazB4Q3B3ZGRHSi1JQUN6Z25nUUFKTlowdXZwRlQ4SFE2NWFDM0tIdExCRzhSWF9hMnZPampJWEVFZWdSU1JYWjRPZThLNTNZUkp0MkhKR2xRelRWQjh2SUxSdFdwVmJiQWxzbzFXeVdEYkRZRDJBUWpJY1FLWW9OR2lqNWRsUQ?oc=5","date":"2023-06-14","type":"pipeline","source":"EU-Startups","summary":"74 Top Biotechnology Startups and Companies in The Netherlands (2021) - EU-Startups","headline":"74 Top Biotechnology Startups and Companies in The Netherlands (2021) - EU","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}